Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5604_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Carbon Based Nanomaterials for Drug Delivery
- •Preface
- •Acknowledgements
- •Contents
- •Editor and Contributors
- •Abbreviations
- •1.2 Market Statistics
- •Carbon-Based Nanomaterials: An Overview
- •1. Introduction
- •1.1 Evolution of Carbon-Based Nanomaterials
- •2. Carbon-Based Nanostructures
- •2.1 Fullerene
- •2.2 Carbon Nanotubes (CNTs)
- •2.4 Graphene
- •2.5 Nanodiamonds (NDs)
- •2.6 Nano-Onions (CNOs)
- •2.7 Nanohorns (CNHs)
- •2.8 Carbon Dots (CDs)
- •2.9 Nanoporous Activated Carbon
- •3. Synthesis Techniques
- •4. Properties of Carbon-Based Nanomaterials
- •4.1 Physicochemical Properties
- •4.2 Thermal Properties
- •4.3 Mechanical Properties
- •4.4 Optoelectronic Properties
- •4.5 Antimicrobial Properties
- •4.6 Biological Properties
- •5. Applications of Carbon-Based Nanomaterials
- •5.1 Environmental Remediation
- •5.2 Agriculture
- •5.3 Biofuel
- •5.4 Energy Storage
- •5.5 Biomedical Applications
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Carbon-Based Nanostructured Materials: Designing, Properties and Applications
- •1. Introduction
- •2.1 Zero-Dimensional Carbon-Based Nanostructures (0D)
- •2.2 One-Dimensional Carbon-Based Nanostructures
- •2.3 Two-Dimensional (2D) Carbon-Based Nanostructures
- •2.4 Three-Dimensional (3D) Carbon-Based Nanostructures
- •3.1 Chemical Vapor Deposition
- •3.2 Hydrothermal and Solvothermal Techniques
- •3.3 Microwave-Assisted Technique
- •3.4 Chemical Oxidation Synthesis
- •4. Properties of Carbon-Based Nanostructured Materials
- •4.1 Thermal Properties
- •4.2 Mechanical Properties
- •4.3 Optoelectronic Properties
- •4.4 Antimicrobial Properties
- •4.5 Biological Properties
- •5. Applications of Carbon-Based Nanostructured Materials
- •5.2 Antibacterial and Antiviral Applications
- •5.3 Theragnostic
- •5.4 Wound Healing
- •5.5 Tissue Engineering
- •5.6 Drug Delivery
- •5.7 Biosensing
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Drug Delivery System and Technologies
- •1. Introduction
- •2. Drug Delivery System
- •2.1 Conventional Drug Delivery System
- •2.2 Advanced Drug Delivery System
- •2.3 Controlled and Sustainable Drug Delivery System
- •3. Drug Delivery Technologies
- •3.1 Active and Passive Drug Delivery
- •3.2 Smart Drug Delivery
- •3.3 Intravenous and Extravaneous Drug Delivery
- •3.4 Various Types of Delivery Technologies
- •4. Challenges and Future Perspectives
- •5. Conclusion
- •References
- •Carbon-Based Nanomaterials for Drug Delivery: Past, Present, Future Directions
- •1. Introduction
- •3. Current Status in Drug Delivery by CNMs
- •3.1 Graphene-Based Nanomaterials in Drug Delivery
- •3.4 Nanodiamond Based Drug Delivery Systems
- •3.5 Nano-Onions in Drug Delivery
- •3.6 Nanohorns in Drug Delivery
- •3.7 Fullerene in Drug Delivery
- •4. Challenges and Future Perspective
- •5. Conclusions
- •References
- •Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •1. Introduction
- •2. Different Carbon Nanomaterials in Drug Delivery
- •2.1 Carbon Nanotubes (CNTs)
- •2.3 Graphene
- •2.4 Carbon Quantum Dots
- •2.5 Fullerene
- •2.6 Carbon Nanohorns
- •2.7 Carbon Nano-Onions
- •2.8 Nano-Diamond
- •3. Supramolecular Chemistry in Drug Delivery
- •3.1 Principles of Supramolecular Chemistry
- •3.3 Applications of Supramolecular Biomaterials
- •4. Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •5.1 Cyclodextrins
- •5.2 Calixarenes
- •5.3 Cucurbituril
- •5.4 Pillarenes
- •5.5 Crown Ether
- •6. Toxicity Concerns of Carbon Nanomaterials
- •7. Improving the Effectiveness of Nanoparticle Systems
- •8. Future of Nanomedicine
- •9.1 Challenges
- •9.2 Future Perspectives and Opportunities
- •9.3 Conclusions
- •References
- •Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug Delivery
- •1. Introduction
- •2.1 Carbon Quantum Dot-Based Polymer Nanocomposite
- •2.2 Carbon Nanotube-Based Polymer Nanocomposite
- •2.3 Graphene Quantum Dot-Based Polymer Nanocomposite
- •2.5 Fullerene-Based Polymer Nanocomposite
- •2.6 Nanodiamond-Based Polymer Nanocomposite
- •3. Drug Delivery Systems Using Carbon Nanomaterial
- •3.1 Anticancer Drug Delivery
- •3.3 Infectious Disease Drug Delivery
- •3.4 Topical Drug Delivery
- •3.5 Brain Drug Delivery
- •3.6 Oral Drug Delivery
- •4. Challenge and Future Perspectives
- •5. Conclusion
- •References
- •Carbon Nanomaterial-Incorporated Polysaccharide-Based Nanocomposite for Drug Delivery
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Carbon Nanomaterials
- •1.3 Polysaccharide-Based Nanocomposite
- •2.1 CN-Incorporated Alginate-Based Nanocomposite
- •2.2 CN-Incorporated Cellulose-Based Nanocomposite
- •2.3 CN-Incorporated Chitosan-Based Nanocomposite
- •2.4 CN-Incorporated Dextran-Based Nanocomposite
- •2.5 CN-Incorporated Hyaluronic Acid-Based Nanocomposite
- •2.6 CN-Incorporated Starch-Based Nanocomposite
- •2.7 CN-Incorporated Pectin-Based Nanocomposite
- •2.8 CN-Incorporated Guar Gum-Based Nanocomposite
- •2.9 CN-Incorporated Agarose-Based Nanocomposite
- •2.10 CN-Incorporated Carrageenan-Based Nanocomposite
- •2.11 CN-Incorporated Glucomannan-Based Nanocomposite
- •3. Challenges and Future Prospective
- •4. Concluding Remarks
- •References
- •Graphene-Based Nanomaterials for Drug Delivery
- •1. Introduction
- •1.1 Challenges in Conventional Drug Delivery Systems
- •1.2 Overview of Nanomaterials for Drug Delivery
- •1.3 Role of Graphene-Based Nanomaterials in Drug Delivery
- •2. Synthesis of Graphene
- •2.1 Chemical Reduction Method
- •2.2 Thermal Reduction
- •2.3 Electrochemical Reduction
- •2.4 Chemical Vapor Deposition Method
- •2.5 Mechanical Exfoliation
- •2.6 Epitaxial Growth Method
- •2.7 Growth in Solvothermal and Hydrothermal Systems
- •2.8 Electrochemical Deposition
- •3. Types of Graphene-Based Materials
- •3.1 Graphene Quantum Dots, (GQDs)
- •3.2 Graphene Oxide (GO)
- •3.3 Graphene Nanoribbons (GNRs)
- •3.4 Oxidized Graphene Nanoribbons
- •4. Graphene Functionalized Materials for Drug Delivery
- •4.1 In Bone Tissue Regeneration
- •4.2 In Neural Regeneration
- •4.3 In Photodynamic and Photothermal Therapy
- •4.4 In Enhancing Cellular and Humoral Immunity
- •4.6 Miscellaneous
- •5. Challenges and Future Perspective
- •6. Conclusion
- •References
- •Carbon Quantum Dots Based Materials for Drug Delivery
- •1. Introduction
- •2. Synthesis Process of Carbon Quantum Dots
- •2.1 Top-Down Approaches
- •2.2 Bottom-Up Approaches
- •2.3 Microwave-Assisted Method
- •2.4 Electrochemical Method
- •2.5 Laser Ablation Method
- •2.6 Pyrolysis Method
- •2.7 Template-Assisted Method
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Carbon-based Nanocarriers for Sustained Drug Release in Dentistry
- •1. Introduction
- •2.1 Oral Mucosa Structure
- •2.2 Sites for Drug Delivery
- •2.3 Permeability
- •3. Local Drug Delivery for Dental Diseases
- •3.1 Odontogenic Infection
- •3.2 Non-odontogenic Infection
- •4. Bio-adhesive Nanoparticles: Novel Treatment Modality
- •4.1 Bio-adhesive Nanoparticles
- •4.2 Mechanism of Bioadhesion
- •5.1 Carbon Nanotubes
- •5.2 Graphene
- •5.3 Nanodiamonds
- •5.4 Fullerenes
- •5.5 Porous Carbon
- •5.6 Carbon Dots
- •6. Drug Delivery Systems Based on CBNs
- •6.2 Immediate Drug Delivery System (IDDS)
- •6.3 Sustained-release Drug Delivery Systems
- •6.4 Controlled Drug Delivery System (CDDs)
- •8. Conclusion
- •References
- •Fullerene Based Materials for Drug Delivery
- •1. Introduction
- •2. Types of Fullerene Derivatives
- •2.1 Exohedral Fullerene Derivatives
- •2.2 Endohedral Fullerene Derivatives
- •2.3 Surface Derivatized Fullerenes
- •3. Interaction of Fullerene Derivatives for Drug Delivery
- •4. Fullerene Based Materials for Drug Delivery
- •4.1 Nucleic Acid Delivery
- •4.2 Peptide Delivery
- •4.3 Topical Drug Delivery
- •4.4 Infectious Diseases Drug Delivery
- •4.5 Anticancer Drug Delivery
- •4.7 Brain Drug Delivery
- •4.8 Ocular Drug Delivery
- •5. Challenges and Future Perspectives
- •6. Concluding Remarks
- •6.1 Abbreviations
- •References
- •Graphene Quantum Dots-based Nanomaterials for Drug Delivery
- •1. Introduction
- •2. Synthesis of GQDs
- •3. GQD’s Properties for Drug Delivery
- •3.1 Optical Properties
- •3.2 Physicochemical Properties
- •3.3 Mechanical Properties
- •3.4 Biocompatibility and Cytotoxicity
- •4. Characterization of GQDs-Based Nanomaterials
- •4.1 Characterization of Multifunctional GQDs-Based Nanomaterials
- •5.1 Strategies for Developing Medication Delivery Systems Based on GQD
- •5.2 PH-responsive Drug Delivery Systems (GQD-DDSs)
- •5.3 Targeted Drug Delivery Using Ligand-Based GQDs as a Mediator
- •5.4 Improvement of Medicines’ Pharmacological Properties Using GQDs
- •5.5 Enhancing Cytotoxicity with GQD-DDS
- •7. Applications of Chiral GQDs
- •10. Challenges and Future Perspectives
- •11. Conclusions
- •References
- •Carbon Nano-onions for Drug Delivery
- •1. Introduction
- •2. Carbon Nano-Onion: A Multi-Layered Nanocarrier
- •3. Synthesis of Carbon Nano-Onions
- •3.1 Annealing Method
- •3.2 Carbon Ion Implantation Method
- •3.3 Arc Discharge Method
- •3.4 Carbon Vapour Deposition Method
- •3.5 Pyrolysis Method
- •6. Carbon Nano-Onions in Drug Delivery
- •6.1 Delivery of Therapeutic Agents
- •6.2 Delivery of Targeting Agents
- •6.3 Delivery of Imaging Agents
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •Chitosan/Carbon Nanocomposites in Drug Delivery and Cardiovascular Diseases
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Cardiovascular Diseases
- •1.3 Chitosan and Its Properties
- •1.4 Chitosan/Carbon Nanocomposites
- •2. Chitosan/Carbon Nanocomposites in Drug Delivery
- •3. Chitosan/Carbon Nanocomposites in CVDs
- •3.1 Chitosan-Based Scaffolds
- •3.2 Chitosan in Cardiac Tissue Engineering
- •3.3 Chitosan-Based Cell Therapy
- •3.4 Chitosan-Based Gene Delivery
- •3.5 Chitosan-Protein Interaction
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Graphene Reinforced Chitosan Nanocomposites for Drug Delivery
- •1. Introduction
- •2. Chitosan: Structure and Properties
- •3. Graphene: Structure, Types and Properties
- •4.1 Electrospinning Method
- •4.2 Sol–gel Method
- •4.3 Solution Mixing Method
- •4.4 In-situ Polymerization Method
- •5.2 Chitosan/Graphene Aerogels
- •5.3 Chitosan/Graphene Hydrogels
- •5.4 Chitosan/Graphene Thin Films
- •6.1 Oral Drug Delivery
- •6.2 Mucosal Drug Delivery
- •6.3 Transdermal Drug Delivery
- •6.4 Parenteral Drug Delivery
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •1. Introduction
- •2. Functionalization of CNFs
- •2.1 The Need for Functionalization

Graphene Reinforced Chitosan Nanocomposites for Drug Delivery 465
12. Gheorghiță D, Moldovan H, Robu A, Bița A-I, Grosu E, Antoniac A, Corneschi I, Antoniac I,
Bodog AD, Băcilă CI (2023) Chitosan-based biomaterials for hemostatic applications: a review
of recent advances. Int J Mol Sci 24:10540
13. Mikušová V, Mikuš P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int
J Mol Sci 22:652
14. Sharma A, Jain N, Sareen R (2013) Nanocarriers for diagnosis and targeting of breast cancer.
Biomed Res Int 2013:960821
15. Vieira IRS, Tessaro L, Lima AKO, Velloso IPS, Conte-Junior CA (2023) Recent progress
in nanotechnology improving the therapeutic potential of polyphenols for cancer. Nutrients
15:3136
16. Saha K, Moyano DF, Rotello VM (2014) Protein coronas suppress the haemolytic activity of
hydrophilic and hydrophobic nanoparticles. Mater Horiz 2014:102–105
17. Li L, Areson C, van der Straten A, Johnson LM (2021) Effects of polymer blending on
the performance of a subcutaneous biodegradable implant for HIV pre-exposure prophylaxis
(PrEP). Int J Mol Sci 18:6529
18. Gomari S, Esfandeh M, Ghasemi I (2017) All-solid-state flexible nanocomposite polymer
electrolytes based on poly(ethylene oxide): lithium perchlorate using functionalized graphene.
Solid State Ionics 303:37–46
19. van der Lubben IM, Verhoef JC, Borchard G, Junginger HE (2001) Chitosan and its derivatives
in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201–207
20. Elieh-Ali-Komi D, Hamblin MR (2016) Chitin and chitosan: production and application of
versatile biomedical nanomaterials. Int J Adv Res (Indore) 4:411–427
21. Jiang S, Qiao C, Wang X, Li Z, Yanga G (2022) Structure and properties of chitosan/sodium
dodecyl sulfate composite films. RSC Adv 12:3969–3978
22. Chen Q, Qi Y, Jiang Y, Quan W, Luo H, Wu K, Li S, Ouyang Q (2022) Progress in research of
chitosan chemical modification technologies and their applications. Mar Drugs 20:536
23. Díaz-Montes E (2022) Polysaccharides: sources, characteristics, properties, and their application in biodegradable films. Polysaccharides 3:480–501
24. Aydin E, Türkez H, Taşdemir S (2013) Anticancer and antioxidant properties of terpinolene in
rat brain cells. Arh Hig Rada Toksikol 64:415–424
25. Andrade MA, Braga MA, Cesar PHS, Trento MVC, Espósito MA, Silva LF, Marcussi S (2018)
Anticancer properties of essential oils: an overview. Curr Cancer Drug Targets 18:957–966
26. Smola-Dmochowska A, Lewicka K, Macyk A, Rychter P, Pamuła E, Dobrzyński P (2023)
Biodegradable polymers and polymer composites with antibacterial properties. Int J Mol Sci
24:7473
27. Tian Y, Wu D, Wu D, Cui Y, Ren G, WangY, WangJ, Peng C (2022) Chitosan-based biomaterial
scaffolds for the repair of infected bone defects. Front Bioeng Biotechnol 10:899760
28. Raafat D, Sahl H-G (2009) Chitosan and its antimicrobial potential – a critical literature survey.
Microb Biotechnol 2:186–201
29. Gu Y, Qiu Z, Müllen K (2022) Nanographenes and graphene nanoribbons as multitalents of
present and future materials science. J Am Chem Soc 144:11499–11524
30. G. Yang, L. Li, W.B. Lee, M. Cheung N, Structure of graphene and its disorders: a review. Sci.
Technol. Adv. Mater. 19, 614 (2018)
31. McCann E (2012) Electronic properties of monolayer and bilayer graphene. Nanosci Technol
57:237–275
32. Gao L, Ren W, Li F, Cheng H-M (2008) Total color difference for rapid and accurate
identification of graphene. ACS Nano 2:1625–1633
33. Feng W, Wang Z (2022) Biomedical applications of chitosan-graphene oxide nanocomposites.
iSci 25:103629
34. Mittal G, Rhee KY, Park SJ, Hui D (2017) Generation of the pores on graphene surface and their
reinforcement effects on the thermal and mechanical properties of chitosan-based composites.
Compos Part B: Eng 114:348–355
35. Dinescu S, Ionita M, Ignat S-R, Costache M, Hermenean A (2019) Graphene oxide enhances
chitosan-based 3D scaffold properties for bone tissue engineering. Int J Mol Sci 20:5077

466 R. Priya et al.
36. Zhang L, Li X, Shi C, Ran G, Peng Y, Zeng S, He Y (2021) Biocompatibility and angiogenic
effect of chitosan/graphene oxide hydrogel scaffolds on EPCs. Stem Cells Int 2021:5594370
37. Maruthupandy M, Rajivgandhi G, Muneeswaran T, Anand M, Quero F (2021) Highly efficient
antibacterial activity of graphene/chitosan/magnetite nanocomposites against ESBL-producing
Pseudomonas aeruginosa and Klebsiella pneumoniae. Colloids and Surf B Bioint 202:111690
38. Pei X, Zhu Z, Gan Z, Chen J, Zhang X, Cheng X, Wan Q, Wang J (2020) PEGylated nanographene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer
activity. Sci Rep 10:2717
39. Jafari Z, Rad AS, Baharfar R, Asghari S, Esfahani MR (2020) Synthesis and application
of chitosan/tripolyphosphate/graphene oxide hydrogel as a new drug delivery system for
Sumatriptan Succinate. J Mol Liquids 315:113835
40. Pal S, Dalal C, Jana NR (2017) Supramolecular host-guest chemistry-based folate/riboflavin
functionalization and cancer cell labeling of nanoparticles. ACS Omega 2:8948–8958
41. Liang Y, Chen B, Li M, He J, Yin Z, Guo B (2020) Injectable antimicrobial conductive hydrogels
for wound disinfection and infectious wound healing. Biomacromol 21:1841–1852
42. Xue J, Wu T, Dai Y, Xia Y (2019) Electrospinning and electrospun nanofibers: methods,
materials, and applications. Chem Rev 119:5298–5415
43. Fathollahipour S, Mehrizi AA, Ghaee A, Koosha M (2015) Electrospinning of PVA/chitosan
nanocomposite nanofibers containing gelatin nanoparticles as a dual drug delivery system. J
Biomed Mater Res A 103:3852–3862
44. Zuo P-P, Feng H-F, Xu Z-Z, Zhang L-F, Zhang Y-L, Xia W, Zhang W-Q (2013) Fabrication
of biocompatible and mechanically reinforced graphene oxide-chitosan nanocomposite films.
Chem Central J 7:39
45. Fahimirad S, Fahimirad Z, Sillanpää M (2021) Efficient removal of water bacteria and viruses
using electrospun nanofibers. Sci Total Environ 751:141673
46. Nassar G, Daou E, Najjar R, Bassil M, Habchi R (2021) A review on the current research on
graphene-based aerogels and their applications. Carbon Trends 4:100065
47. Teo N, Jana SC (2018) Solvent effects on tuning pore structures in polyimide aerogels.
Langmuir 34:8581–8590
48. Yousefi N, Abbasi S (2022) Food proteins: Solubility & thermal stability improvement
techniques. Food Chem Adv 1:100090
49. Danks AE, Hall SR, Schnepp Z (2016) The evolution of ‘sol–gel’ chemistry as a technique for
materials synthesis. Mater Horiz 3:91–112
50. Szabó L, Milotskyi R, Sharma G, Takahashi K (2023) Cellulose processing in ionic liquids
from a materials science perspective: turning a versatile biopolymer into the cornerstone of our
sustainable future. Green Chem 25:5338–5389
51. Yuan H, Meng L-Y, Park S-J (2016) A review: synthesis and applications of graphene/chitosan
nanocomposites. Carbon Lett 17:11–17
52. Velusamy S, Roy A, Sundaram S, Mallick TK (2021) A review on heavy metal ions
and containing dyes removal through graphene oxide-based adsorption strategies for textile
wastewater treatment. Chem Rec 21:1–42
53. de Sousa M, Visani de Luna LA, Fonseca LC, Giorgio S, Alves OL (2018) Folic-acidfunctionalized graphene oxide nanocarrier: synthetic approaches, characterization, drug
delivery study, and antitumor screening. ACS Appl Nano Mater 1:922–932
54. Bellier N, Baipaywad P, Ryu N, Lee JY, Park H (2022) Recent biomedical advancements in
graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers. Biomat Res
26:65
55. Yang S, Zhang X, Zhang D (2019) Electrospun chitosan/poly (vinyl alcohol)/graphene
oxide nanofibrous membrane with ciprofloxacin antibiotic drug for potential wound dressing
application. Int J Mol Sci 20:4395
56. Liu P, Chen X, Li Y, Cheng P, Tang Z, Lv J, Aftab W, Wang G (2022) Aerogels meet phase
change materials: fundamentals, advances, and beyond. ACS Nano 16:15586–15626
57. Guerrero-Fajardo CA, Giraldo L, Moreno-Piraján JC (2020) Preparation and characterization
of graphene oxide for Pb(II) and Zn(II) ions adsorption from aqueous solution: experimental,
thermodynamic and kinetic study. Nanomaterials (Basel) 10:1022

Graphene Reinforced Chitosan Nanocomposites for Drug Delivery 467
58. Zhu W,Jiang X, Liu F,You F,Yao C (2020) Preparation of chitosan—graphene oxide composite
aerogel by hydrothermal method and its adsorption property of methyl orange. Polym 12:2169
59. Wan S, Zhang Q, Zhou X, Li D, Ji B, Jiang L, Cheng Q (2017) Fatigue resistant bioinspired
composite from synergistic two-dimensional nanocomponents. ACS Nano 7:7074–7083
60. Jacob S, Nair AB, Shah J, Sreeharsha N, Gupta S, Shinu P (2021) Emerging role of hydrogels
in drug delivery systems, tissue engineering and wound management. Pharm 13:357
61. Wang Q, Zhang Y, Ma Y, Wang M, Pan G (2023) Nano-crosslinked dynamic hydrogels for
biomedical applications. Mater Today Biol 20:100640
62. Liang Y, Li M, Yang Y, Qiao L, Xu H, Guo B (2022) PH/glucose dual responsive metformin
release hydrogel dressings with adhesion and self-healing via dual-dynamic bonding for athletic
diabetic foot wound healing. ACS Nano 16:3194–3207
63. Hamghavandi MR, Montazeri A, Daryakenar AA, Pishvaei M (2021) Preparation and characterization of chitosan/graphene oxide nanocomposite coatings on Mg-2 wt% Zn scaffold by
pulse electrodeposition process. Biomed Mater 16
64. Jafernik K, Ładniak A, Blicharska E, Czarnek K, Ekiert H, Wiącek AE, Szopa A (2023)
Chitosan-based nanoparticles as effective drug delivery systems—a review. Molecules 28:1963
65. Ahmadvand H, Ghasemi-Dehnoo M (2014) Antiatherogenic, hepatoprotective, and hypolipidemic effects of coenzyme Q10 in alloxan-induced type 1 diabetic rats. Arya Atheroscler
10:192–198
66. Wing-Fu L, Wing-Tak W (2021) Use of graphene-based materials as carriers of bioactive
agents. Asian J Pharm Sci 16:577–588
67. Kaur P, Garg T, Rath G, Goyal AK (2016) In situ nasal gel drug delivery: A novel approach for
brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol 44:1167–1176
68. Bandi SP, Bhatnagar S, Venuganti VVK (2021) Advanced materials for drug delivery across
mucosal barriers. Acta Biomater 119:13–29
69. Shaikh R, Singh TRR, Garland MJ, Woolfson AD, Donnelly RF (2011) Mucoadhesive drug
delivery systems. J Pharm Bioallied Sci 3:89–100
70. Watchorn J, Clasky AJ, Prakash G, Johnston IAE, Chen PZ, Gu FX (2022) Untangling mucosal
drug delivery: engineering, designing, and testing nanoparticles to overcome the mucus barrier.
ACS Biomater Sci Eng 8:1396–1426
71. Chonkar A, Nayak U, Udupa N (2015) Smart polymers in nasal drug delivery. Indian J Pharm
Sci 77:367–375
72. Netsomboon K, Bernkop-Schnürch A, Mucoadhesive vs. mucopenetrating particulate drug
delivery. Eur J Pharm Biopharm 98:76–89
73. Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G (2015) Transmucosal delivery of
docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol 43:263–269
74. Shataer M, Shataer S, Libin L, Tian L, Shengbin B (2020) Histological comparison of two
special methods of staining melanin in human skin. Int J Morphol 38:1535–1538
75. Zhou H, Lu H (2021) Advances in the development of anti-adhesive biomaterials for tendon
repair treatment. Tissue Eng Regen Med 18:1–14
76. Coelho JF, Ferreira PC, Alves P, Cordeiro R, Fonseca AC, Góis JR, Gil MH (2010) Drug
delivery systems: advanced technologies potentially applicable in personalized treatments.
EPMA J 1:164–209
77. Waghule T,Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, Dua K (2019) Microneedles:
A smart approach and increasing potential for transdermal drug delivery system. Biomed Pharm
109:1249–1258
78. Raina N, Rani R, Thakur VK, Gupta M (2023) New insights in topical drug delivery for skin
disorders: from a nanotechnological perspective. ACS Omega 8:19145–19167
79. Laffleur F, Keckeis V (2020) Advances in drug delivery systems: work in progress still needed?
Int J Pharm X 2:100050
80. Ma J, Wang Y, Lu R (2022) Mechanism and application of chitosan and its derivatives in
promoting permeation in transdermal drug delivery systems: a review. Pharmaceuticals 15:459
81. Saidin NM, Anuar NK, Affandi MMRMM (2018) Roles of polysaccharides in transdermal
drug delivery system and future prospects. J Appl Pharm Sci 8:141–157

468 R. Priya et al.
82. Eltahir S, Al homsi R, Ahmed IS, Haider M (2022) Graphene oxide/chitosan injectable
composite hydrogel for controlled release of doxorubicin: an approach for enhanced intratumoral delivery. Nanomaterials 12: 4261
83. Schwartz GN, Pendyala L, Kindler H, Meropol N, Perez R, Raghavan D, Creaven P (1998)
The clinical development of paclitaxel and the paclitaxel/carboplatin combination. Eur J Cancer
34:1543–1548
84. Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different
mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7:339–348
85. Bukowski K, Kciuk M, Kontek R (2017) Mechanisms of multidrug resistance in cancer
chemotherapy. Int J Mol Sci 21:3233
86. Joseph TM, Mahapatra DK, Esmaeili A, Piszczyk Ł, Hasanin MS, Kattali M, Haponiuk J,
Thomas S (2023) Nanoparticles: taking a unique position in medicine. Nanomat 13:574

Carbon Nanofiber-Based Materials
for Drug Delivery
Namrata Khanna, Tanushri Chatterji, and Tanya Bhagat
Abstract Polymeric nanofibers with their large surface area per unit mass, biocom-
patibility, easy fabrication and surface modification find extensive use as filters and
scaffolds in several biomedical applications like precision drug delivery, tissue engineering, formation of reinforced composite molecules and sensors. Though most
of these applications are in nascent stages of development, some are being used
commercially. Several strategies have been employed for development of nanofibers,
but electrospinning technique has been used widely to modify several polymers into
nanofibers and is probably the only strategy with potential for large-scale commercial
production. It is a versatile process and has the ability to fabricate several nanofiber
assemblies by enhancing the performance and introducing variations conducive for
specific applications. Organic, inorganic or hybrid nanofibers exhibit refined mechanical features for enhanced sustained release or for regulated release of loaded drugs,
which facilitates the application of nanofibers in precise delivery of drugs. This
chapter provides a succinct account of the progress in preparation, performance and
application of several nanofibers as drug delivery carriers for anti-inflammatory,
antimicrobial, antitumor, cardiovascular, gastrointestinal and palliative therapies,
emphasizing role of electrospinning process in the above applications.
·
Keywords Carbon nanofibers
Electrospinning · Drug delivery
N. Khanna
Department of Biochemistry, M. A. Rangoonwala College of Dental Sciences and Research
Centre, 2390-B, K.B. Hidayatullah Road, Azam Campus, Camp, Pune, Maharashtra 411001, India
T. Cha tter ji (
Department of Biosciences, Institute of Management Studies Ghaziabad (University Courses
Campus), Adhyatmik Nagar, NH-09, Ghaziabad, Uttar Pradesh 201015, India
e-mail: tanushri@gmail.com
T. Bhagat
Department of Biochemistry, Manav Rachna International Institute of Research and Studies,
Sector – 43, Aravalli Hills, Delhi – Surajkund Road, Faridabad, Haryana 121004, India
) · T. Bhagat
B
Surface modification·Polymers
·
469

470 N. Khanna et al.
Abbreviations
AC Aceclofenac
ACV Acyclovir
AMB Amphotericin B
AMOX Amocycilin
APAP Acetaminophen; N-acetyl-para-aminophenol
APIs Active pharmaceutical ingredients
CAF Caffeine
CAP Cellulose acetate phthalate
CHS Chitosan
CIPRO Ciprofloxacin
DMAc Dimethylacetamide
CNTs Carbon nanotubes
CNFs Carbon nanofibers
DOC Docetaxel
DOX Doxorubicin
DPH Diphenhydramine
DSC Differential scanning calorimetry
EC Ethyl cellulose
GML Glycerol Monolaurate
GRIS Griseofulvin
HOPG Highly oriented pyrolytic graphite
HPMC Hydroxypropylmethyl cellulose
IBU Ibuprofen
INDO Indomethacin
ITR Itraconazole
KETO Ketoprofen
LOR Loratadine
MEL Meloxicam
MET-HCl Metoclopramide hydrochloride
MWCNT Multi-walled carbon nanotube
PAA Poly(acrylic acid)
PAN Poly(acrylonitrile)
PCL Poly(ε-caprolactone)
PEO Poly(ethylene oxide)
PLGA Poly(lactic-co-glycolic acid)
PLLA Poly(L- lactic acid)
PTX Paclitaxel
PU Poly (urethane)
PVAL Poly(vinyl alcohol)
PVP Poly(vinylpyrrolidone)
RFN Riboflavin
SDS Sodium dodecylsulfate

Carbon Nanofiber-Based Materials for Drug Delivery 471
SPIRO Spirolactone
SWCNT Single walled carbon nanotube
SUM Sumatriptan
TCH Tetracycline hydrochloride
TCN Tetracycline
TGA Thermo-gravimetric analysis
TDF Tenofovir disoproxil fumarate
1 Introduction
Among nanomolecules, carbon nanotubes (CNTs) and nanofibers (CNFs) have drawn
wide recognition owing to their structural, electrical, mechanical, thermal and optical
characteristics. CNTs are well-arranged hollow structures made up of carbon atoms
linked through strong sp
ical strength, along with electrical and thermal conductivity to the CNTs [1–4].
CNTs can be visualized as cylindrical structures, which are formed by a graphene
sheet (Fig. 1a and b). A single graphene sheet on rolling creates a single walled
carbon nanotube (SWCNT), whereas multiple concentric graphene sheets form a
multi-walled carbon nanotube (MWCNT). Alignment of atoms in carbon nanofibers
(CNFs) is less refined. A CNF is formed when graphene sheets bend at a certain
angle, α, resulting in stacks of conical nanostructures (Fig. 1c), while CNTs exhibit
α = 0 (Fig. 1b). SWCNTs have diameters within a range of 0.5 to 1.5 nm and length
in a range of 100 nm to many micrometers. MWCNTs possess bigger diameters
(above 100 nm), owing to a multilayered structure. Diameter of CNFs can range
from 3.5 nm to a few hundred nanometers and length can be up to many micrometers. Transmission electron microscopy (TEM) images of MWCNT and CNFs are
represented in Fig. 1(d–f).
Exceptional electrical, surface and mechanical features make CNFs perfect for
several biomedical applications. Their high aspect ratio (length to diameter ratio),
large surface area and several dangling bonds along the side walls provide CNFs with
the flexibility to be modified by many bioactive molecules for clinical application.
The current chapter reviews the use of CNFs in precision drug delivery, which is
critical in treatment of several malignancies and other disorders. CNFs have the
advantage of low production cost in comparison with CNTs, which facilitates their
involvement in commercial production. CNFs are composed of graphene and exhibit
different planes which are not concentric. Based on structure, they are classified as
[5]“platelet,” “fishbone,” “ribbon,” or “stacked cup.”
2
bonds, which are critical in providing high mechan-

472 N. Khanna et al.
Fig. 1 Representation of a graphene sheet b CNT c and nanofiber structures (Reproduced with
permission from AIP Publishing [4]), TEM pictures showing cross section of d MWCNT (Repro-
duced with permission from Elsevier [1]) and e and f nanofiber (Reproduced with permission from
ACS [2])
2 Functionalization of CNFs
Though there are differences in their structure, CNFs are related to CNTs as the CNFs
have morphology similar to MWCNTs; nevertheless, they have distinct chemical
and physical characteristics. CNTs exhibit ballistic transport of electrons [6] and an
axial diamond-like tensile strength [7]. The strength of nanofibers is proved by their
individual, independent configuration, which exhibits a high reactivity and electron
transfer beyond the sidewalls of nanofibres, a significant aspect in facilitating their
functionalization [8–10] and utilization of electrochemical technique [8, 10, 11],
respectively. Initial studies on highly oriented pyrolytic graphite (HOPG) and glassy
carbon show that in graphite, the edge planes have 105 times higher electron transport
rates as compared to those exhibited by basal planes [11].

Carbon Nanofiber-Based Materials for Drug Delivery 473
2.1 The Need for Functionalization
Functionalization of nanofibres is similar to that of nanotubes and has been reviewed
by Klein et al. [3]. Functionalization of CNFs involves reactions at the fibre surface,
while for CNTs, the sidewalls along with tube caps are the sites of chemical reactions.
Pristine carbon nanomaterials aggregate as bundles and are insoluble [12]; hence,
they are difficult for biomedical application. Some non-functionalized nanoparticles
exhibit cytotoxicity [13–15], which is attributed to the presence of residual metallic
catalysts and also to the insoluble character of pristine nanoparticles [16]. Therefore, to make them biocompatible, functionalization is significant, as it enhances
the solubility and decreases their cytotoxicity. Furthermore, conjugation of bioactive materials with the nanoparticle through the process of functionalization aids in
carrying drugs, antigens and gene towards target tissues.
2.2 Techniques Employed for Functionalization of Carbon
Nanomaterials
Various strategies for functionalization are employed and mainly involve two
approaches, the first strategy involves additional reactions for attachment of organic
moieties on the sidewalls and tips and the second approach includes oxidation along
with carboxyl couplings. The first strategy involves blending of pristine carbon
nanoparticles and aniline and the pressure applied during mixing facilitates liberation of the bundled outer nanoparticles, which react with the reagent to initiate
the process of functionalization. This leads to covalent functionalization of the
individual nanoparticle, which prevents it from bundling with other particles and
increases surface area for attachment of molecules along with improving the solubility. This strategy is a simple procedure, which generates soluble nanoparticles and
facilitates their industrial application [17]. However, this method has a major limitation of preventing many essential changes in the nanoparticle. The second method
used for functionalization involves oxidation and couplings that are carboxyl group
based. This procedure involves creation of cap openings and holes along the side
walls through oxidation, which uses concentrated acids. Furthermore, carboxylic
groups are also introduced, which increase the solubility of nanoparticles in aqueous
medium [18]. Carboxylic group forms amide and ester linked covalent bonds with
several biologically active molecules such as peptides [19, 20], nucleic acids [21, 22],
proteins [23] and anti-tumor drugs [24, 25]. Appropriate bonding enhances solubility
of nanoparticles in both aqueous [26] as well as organic solvents [27]. Carboxylic
functional groups decrease interactions driven by Van der Waals forces between the
nanoparticles, facilitating separation of bundles [28].

474 N. Khanna et al.
3 Electrospinning of Nanofibers
Electrospinning is a process employing electrostatic forces to generate extremely
fine fibers with size in the range of submicron to nanometer. Electrospinning can be
used to produce nanofibers which can be natural [29], synthetic [30], biodegradable
[31, 32], non-degradable [33] or combinations of the above types [31, 34]. Though,
there are many traditional strategies for nanofiber fabrication like template synthesis
[35, 36], phase separation [37], mechanical drawing [38] and self-assembly [36,
39, 40], electrospinning has attracted more attention and is widely accepted as it is
easy to perform, is cost effective, needs uncomplicated tools, and produces ultrafine
nanofibers by employing a simple step-up production.
The process involves a high voltage electric field, which on application to the
nanofiber fluid (in solution or molten) causes generation of a jet, which ejects from
the eluting nozzle and proceeds towards the grounded collector that is oppositely
charged. In absence of an electric field, surface tension holds the nanofiber droplet at
the tip of capillary [41, 42]. On applying the electrostatic forces, the surface tension
gets balanced and the droplet elongates to form a “Taylor Cone.” When the electrical
field is strong enough to balance the surface tension, a fine jet ejects out through the tip
of the cone [43, 44]. When liquid jet passes in air, the fluid evaporates and solidified
nanofibers are collected in the form of a scaffold or mesh [45]. The electrospinning
process is illustrated in Fig. 2.
Nanofibers spun by traditional methods are thinned and elongated by aerodynamic, rheological, tensile, gravitational, or inertial forces [46]. The charge induced
by effect of electric field generates tensile forces towards the direction of axial jet
flow, which causes spinning of the fiber [47]. Recent studies exhibit that the jet,
after traversing a short distance, loses stability and whips owing to reciprocal action
between the external electrostatic force of attraction and the internal forces of repulsion generated by surface charges in the jet [48]. This causes elongation of length and
reduction in diameter of the nanofiber manifold as compared to nanofibers generated
Fig. 2 The process of electrospinning employed for generating and improving the structure of
nanofibers. Adapted with permission from RSC [45]
Соседние файлы в папке Библиотека им академика М.И. Перельмана
